entertainment -WSS

entertainment

author：hotspot 2025-10-01 02:13:53 - browse：439

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Seven months after US drug regulators fully approved Biogen’s treatment for Alzheimer’s disease, only about 2,000 patients are taking the medicine nationwide, the company said Tuesday.

Biogen’s chief executive, Christopher A. Viehbacher, said as the firm released fourth-quarter earnings that he had expected the slow uptake and sees considerable demand for the medication. He told reporters that 3,800 patients with early-stage Alzheimer’s have signed up on multiple registries to receive the drug, called Leqembi, as of last month.

Before patients can get the drug, which costs $26,500-a-year, they must undergo a brain scan or a spinal tap to confirm that they have build-up of deposits of a sticky toxic protein called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Naloxone nonprofit donates 200,000 doses after FDA approval

WSS

FDA panel issues narrow recommendation for Covid vaccine booster doses

10 reasons why health care startups fail

Why you shouldn’t ask, “What country has the best health care?”

American woman, child freed after being kidnapped in Haiti last month

Man killed during FBI raid in connection with threats against Biden, other officials

Bernie Sanders is gearing up to subpoena pharma CEOs

hotspot

entertainment

leisure time

Activists slam private health insurers over coverage restrictions

Man killed during FBI raid in connection with threats against Biden, other officials

Peter Hotez and the public health issue of online harassment

New clues to why women have higher risk of autoimmune disorders

As demand for Covid shots wanes, Moderna seeks its next success

FTC sues over Novant Health acquisition of two N.C. hospitals

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Boston competes with Raleigh

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Syphilis numbers in the United States reach record heights

hotspot

Maui's cultural, historic landmarks damaged in the devastating wildfires

Wegovy leads to weight loss. Can it treat depression, too?

American woman, child freed after being kidnapped in Haiti last month

Pancreatic cancer early detection could be helped by AI

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Why Medicare shouldn’t cover every FDA

focus

focus

hotspot

focus